Search research articles
Contact Us
Filters
Showing results (31-40 of 67) with videos related to
Page
of 7
Sort By:
Orphanet Journal of Rare Diseases
|
July 15, 2025
A father's crusade in rare disease drug development: a case study of Elpida therapeutics and Melpida
Deanna Portero, Qingyang Xu, Aaliya Hussain, et al.
Drug Discovery Today
|
December 13, 2025
Genetic Targets, Financial Creativity: BridgeBio's Model for Sustainable Drug Development
Chinmay Shukla, Irwin Tendler, Neil Kumar, et al.
Science Translational Medicine
|
June 20, 2014
Parallel discovery of Alzheimer's therapeutics
Andrew W Lo, Carole Ho, Jayna Cummings, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
October 26, 2022
Incorporating patient preferences and burden-of-disease in evaluating ALS drug candidate AMX0035: a Bayesian decision analysis perspective
Qingyang Xu, Joonhyuk Cho, Zied Ben Chaouch, et al.
JAMA Oncology
|
October 30, 2015
Health, Wealth, and the 21st Century Cures Act
Andrew W Lo, Tomas J Philipson, Andrew C von Eschenbach
Contemporary Clinical Trials Communications
|
April 18, 2025
Predicting clinical trial duration via statistical and machine learning models
Joonhyuk Cho, Qingyang Xu, Chi Heem Wong, et al.
Drug Discovery Today
|
May 1, 2017
Accelerating biomedical innovation: a case study of the SPARK program at Stanford University, School of Medicine
Esther S Kim, Paige M C Omura, Andrew W Lo
JAMA Oncology
|
June 4, 2018
New Business Models to Accelerate Innovation in Pediatric Oncology Therapeutics: A Review
Sonya Das, Raphaël Rousseau, Peter C Adamson, et al.
Journal of Multimorbidity and Comorbidity
|
June 7, 2022
Multimorbidity and mortality: A data science perspective
Kien Wei Siah, Chi Heem Wong, Jerry Gupta, et al.
Drug Safety
|
May 17, 2022
Identifying and Mitigating Potential Biases in Predicting Drug Approvals
Qingyang Xu, Elaheh Ahmadi, Alexander Amini, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 67) with videos related to
Sort By:
Page
of 7
Orphanet Journal of Rare Diseases
|
July 15, 2025
A father's crusade in rare disease drug development: a case study of Elpida therapeutics and Melpida
Deanna Portero, Qingyang Xu, Aaliya Hussain, et al.
Drug Discovery Today
|
December 13, 2025
Genetic Targets, Financial Creativity: BridgeBio's Model for Sustainable Drug Development
Chinmay Shukla, Irwin Tendler, Neil Kumar, et al.
Science Translational Medicine
|
June 20, 2014
Parallel discovery of Alzheimer's therapeutics
Andrew W Lo, Carole Ho, Jayna Cummings, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
October 26, 2022
Incorporating patient preferences and burden-of-disease in evaluating ALS drug candidate AMX0035: a Bayesian decision analysis perspective
Qingyang Xu, Joonhyuk Cho, Zied Ben Chaouch, et al.
JAMA Oncology
|
October 30, 2015
Health, Wealth, and the 21st Century Cures Act
Andrew W Lo, Tomas J Philipson, Andrew C von Eschenbach
Contemporary Clinical Trials Communications
|
April 18, 2025
Predicting clinical trial duration via statistical and machine learning models
Joonhyuk Cho, Qingyang Xu, Chi Heem Wong, et al.
Drug Discovery Today
|
May 1, 2017
Accelerating biomedical innovation: a case study of the SPARK program at Stanford University, School of Medicine
Esther S Kim, Paige M C Omura, Andrew W Lo
JAMA Oncology
|
June 4, 2018
New Business Models to Accelerate Innovation in Pediatric Oncology Therapeutics: A Review
Sonya Das, Raphaël Rousseau, Peter C Adamson, et al.
Journal of Multimorbidity and Comorbidity
|
June 7, 2022
Multimorbidity and mortality: A data science perspective
Kien Wei Siah, Chi Heem Wong, Jerry Gupta, et al.
Drug Safety
|
May 17, 2022
Identifying and Mitigating Potential Biases in Predicting Drug Approvals
Qingyang Xu, Elaheh Ahmadi, Alexander Amini, et al.
Page
of 7